A carregar...
Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine
First line treatment for pancreatic cancer consists of surgical resection, if possible, and a subsequent course of chemotherapy using the nucleoside analogue gemcitabine. In some patients, an active transport mechanism allows gemcitabine to enter efficiently into the tumor cells, resulting in a sign...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4941374/ https://ncbi.nlm.nih.gov/pubmed/26959746 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7931 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|